P- Reviewer: Izbicki JR, Lodge JP S- Editor: Qi Y L- Editor: A E- Editor: Lu YJ
Published online Jul 15, 2016. doi: 10.4251/wjgo.v8.i7.550
Peer-review started: January 4, 2016
First decision: February 1, 2016
Revised: March 9, 2016
Accepted: April 20, 2016
Article in press: April 22, 2016
Published online: July 15, 2016
AIM: To report our experience on management of colorectal neoplasia during pregnancy and in the postpartum period.
METHODS: Patients who were diagnosed with colorectal cancer during pregnancy or in the postpartum period (< 6 mo), between 8/1997 and 4/2013, in our department were reviewed. Patient characteristics, operations, fetal health and follow-up during pregnancy, type of delivery and oncologic outcomes were analyzed.
RESULTS: Eight patients met our study criteria. Median age at the time of diagnosis of colorectal cancer was 31 years. Median follow-up after surgery was 36 mo. Median duration of symptoms before diagnosis was 16 wk. Three patients were diagnosed with colorectal cancer during pregnancy and underwent surgery prior to delivery. None of the patients received adjuvant treatment during pregnancy. Five patients were diagnosed with colorectal cancer within a median of 2.1 mo after delivery and underwent surgery. No adverse neonatal outcomes were noted. All deliveries were at term (2 cesarean sections) except for one preterm delivery following low anterior resection on the 34th week of pregnancy.
CONCLUSION: There has been a significant delay in the diagnosis of colorectal cancer which is probably due to overlap of symptoms and signs between these tumors and a normal pregnancy. Surgery for colorectal cancer during pregnancy can be performed safely without compromising maternal and fetal outcomes.
Core tip: This paper summarizes the experience of a tertiary referral colorectal center in the United States on the management of colorectal neoplasia during the pregnancy and postpartum period. Eight patients who were diagnosed with colorectal cancer during pregnancy or in the postpartum period between 8/1997 and 4/2013 were reviewed. No maternal and neonatal mortality occurred related to surgical treatment. While surgery for colorectal cancer during pregnancy can be performed safely and may not affect maternal and fetal outcomes adversely, there has been a significant delay in the diagnosis of colorectal cancer which is probably due to overlap of symptoms and signs between these tumors and a normal pregnancy.
- Citation: Aytac E, Ozuner G, Isik O, Gorgun E, Stocchi L. Management of colorectal neoplasia during pregnancy and in the postpartum period. World J Gastrointest Oncol 2016; 8(7): 550-554
- URL: https://www.wjgnet.com/1948-5204/full/v8/i7/550.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i7.550
While the incidence of colorectal cancer is steady or falling, some studies report an increased incidence of colorectal cancer in younger patients (< 40 years), which may occur during the reproductive age and therefore interfere with pregnancy. Around 0.1% of pregnant women develop a malignancy and there is limited experience on the management of colorectal cancer diagnosed during pregnancy or in the postpartum period. When colorectal cancer is detected in this period, treatment options may be limited. As two patients with possibly conflicting interests need to be managed, many ethical, psycho emotional and medical issues need to be simultaneously addressed. In this study, we analyzed management, complications, maternal and fetal outcomes in patients who were diagnosed with colorectal cancer during pregnancy or in the immediate postpartum period.
After obtaining the institutional review board approval (IRB), patients who were diagnosed with colorectal cancer during pregnancy or in the postpartum period and treated at the Department of Colorectal Surgery Cleveland Clinic Ohio, from August 1997 to April 2013, were analyzed in the study. The postpartum period is defined as first 6 mo after delivery. Patient characteristics, cancer follow-up, history of previous pregnancies, medications used during pregnancy, indication for surgery, operations performed, outcomes after surgery, complications, maternal and fetal morbidity and mortality during perinatal period and type of delivery were analyzed. Data were retrieved from the IRB approved prospectively maintained databases with supplemental information from patient charts. A multidisciplinary team including gastroenterologists, oncologists, obstetricians and colorectal surgeons followed up all patients.
Quantitative data were reported as median (range) and categorical data as numbers.
Eight patients met our study criteria. Median age at the time of diagnosis of colorectal cancer was 31 (24-38) and median body mass index was 24 (19-27) kg/m2. Median follow-up after surgery was 36 mo (0.2-192). Two patients had a family history of hereditary non-polyposis colorectal cancer and one had juvenile polyposis syndrome. Four patients were nulliparous, the remaining 4 patients had a history of previous successful pregnancies. The presenting symptoms, duration of symptoms, tumor location and treatment strategy are listed in the Table 1. Median duration of symptoms before diagnosis was 16 (4-43) wk. Three patients were diagnosed with colorectal cancer during pregnancy and underwent surgery prior to delivery. These cases included 1 anterior resection with an end colostomy in the 18th week, 1 low anterior resection in the 24th week and 1 subtotal colectomy during the 8th week of pregnancy. Five patients were diagnosed with colorectal cancer within a median of 2.1 (1-4.2) mo after delivery. One synchronous low anterior resection and liver resection, 1 extensive left colectomy, 1 transanal resection, 1 ileocecal resection, and 1 right colectomy were performed on those patients. No adverse neonatal outcomes were noted. All deliveries were at term, except for one patient who underwent low anterior resection during pregnancy (34th week) and delivered preterm. Two patients underwent a cesarean section. Median APGAR score was 9 (8-9). Median birth weight was 3100 (3000-3800) g.
|Stage||Start of symptom (pregnancy week)||Duration of symptoms until diagnosis (wk)||Symptom||Tumorlocation||NCRT||Postoperativechemotherapy||Postoperativeradiotherapy||Status at last follow-up|
|11,2||I||4||10||Rectal bleeding||Sigmoid colon||-||-||-||Alive (NED)|
|21,2||III||13||4||Rectal bleeding||Rectum||-||+||-||Alive (NED)|
|31,2||III||16||7||Rectal bleeding||Rectum||-||+||-||Alive (NED)|
|41,3||I||36||17||Rectal bleeding||Rectum||-||-||-||Alive (NED)|
|51,3||III||34||14||Abdominal pain||Right colon||-||-||-||Alive (NED)|
|61,3||III||20||24||Rectal bleeding||Rectum||-||+||-||Alive (NED)|
|83||IV||12||43||Anemia, abdominal pain||Right colon||-||+||-||Deceased|
Adjuvant or neoadjuvant treatments were administered exclusively after delivery. In particular, one patient received neoadjuvant chemoradiotherapy whereas adjuvant chemotherapy was given to 5 patients. The specific chemotherapeutic regimens were 5-florouracil with leucovorin (n = 2), FOLFOX (n = 2) and FOLFIRI (n = 1). In long-term follow-up, two patients had further successful pregnancies. One of these patients had a ventral hernia repair. The patient initially treated with transanal excision of a T1 rectal lesion opted in favor of radical surgery after delivery and underwent low anterior resection.
Our study shows that surgical intervention can be safe and feasible in patients who are diagnosed with colorectal cancer during pregnancy or in the postpartum period. All of our patients who were diagnosed with colorectal cancer after delivery, had symptoms during pregnancy. Normal pregnancy can mask the symptoms and signs associated with colorectal malignancy[2,4,5]. For example, abdominal pain, intermittent rectal bleeding and anemia can occur during the course of pregnancy. Occasional abdominal pain can be related to an enlarging uterus and uterine cramps. Hemorrhoids or anal fissure can be common causes of rectal bleeding in pregnant women. Pregnancy can limit the utilization of standard diagnostic and therapeutic tools due to a gravid uterus and a potentially vulnerable fetus, which in particular can hamper the liberal use of colonoscopy and computed tomography. However, all patients in our study group underwent complete colonoscopic evaluation before surgery. The age of diagnosis and tumor characteristics in our patients are similar to other series.
Ultrasonography (USG), magnetic resonance imaging (MRI) or computed tomography (CT) were used for disease staging in our series. USG, MRI and CT can be used during pregnancy after consenting the patients about the associated risks and benefits. Heat effects of the magnetic field can be risky for the fetus, especially in the first trimester[9,10]. CT scan has a limited role in pregnancy due to radiation and contrast. Proctosigmoidoscopy may be very helpful for differential diagnosis since more than 85% of colorectal tumors diagnosed during pregnancy appear to develop below the peritoneal reflection. In addition, common anorectal problems can be excluded with a careful anorectal exam. In our series, 5 patients had rectal and 1 patient had a sigmoid colon cancer. Diagnosis of colorectal cancer at an early stage would result in better outcomes. Gastrointestinal symptoms should not be overlooked in a pregnant woman and should be evaluated with proper diagnostic modalities.
According the American Society of Gastrointestinal Endoscopy guidelines, an endoscopic intervention is safer than radiologically guided or surgical operations. It is preferable to postpone endoscopy to the second trimester. However, patients should be informed about the potential side effects including over sedation leading to hypoventilation or hypotension, teratogenic effects of medications used for sedation and premature birth. We did not experience any complications patient or fetus related in our diagnostic work-up. Familial adenomatous polyposis is a known risk factor for colorectal cancer during pregnancy. In our cohort, 2 patients had a family history of HNPCC and both of these patients were later confirmed with positive genetic testing. One of our patients had juvenile polyposis syndrome and diagnosed with a right colon cancer but later expired due to metastatic disease. In this particular patient diagnosis was delayed 43 mo and was diagnosed in the postpartum period.
The treatment strategy for colorectal cancer should be no different for pregnant and non-pregnant patients in terms of the aim which is potential curative treatment of the disease. However, the well-being of the fetus should be considered. Termination of ongoing pregnancy or delay of required treatment should be discussed with the patient according to time of pregnancy and patient’s preference[2,6,15]. The first trimester of pregnancy is not appropriate for chemotherapy because of high risk of fetal malformations. While it is generally recommended that chemotherapy should be given only after delivery, there are some reports suggesting that chemotherapy can be given in the second trimester without causing significant long-term complications[6,17,18]. However, it has been reported that the administration of 5-florouracil during pregnancy may cause spontaneous abortion. If maternal and/or fetal healths are threatened, preterm delivery can be considered. Walsh et al have proposed an algorithm to manage colorectal cancer diagnosed during pregnancy and recommend individualized treatment based on the disease stage and time of diagnosis during pregnancy. Acting as a team during follow-up and including the patient in decision making are advised.
While low patient number and retrospective design are the major drawbacks of the study, our study is one of the largest single center experiences on this topic. In our limited experience with three patients who have undergone surgery during pregnancy, no adverse maternal and fetal outcomes were observed. There has been a significant delay in the diagnosis of these tumors which is probably due to overlap of symptoms and signs between colorectal malignancy and a normal pregnancy.
Poster presentation at the meeting of the American Society of Colon and Rectal Surgeons, 2014. Erman Aytac is an assistant professor of surgery at the Acibadem University in Istanbul, Turkey.
Colorectal cancer in pregnancy is a rare condition and the literature on this subject is scant with fewer than 300 cases reported. The diagnosis of colorectal cancer in pregnancy is usually delayed because the individuals are young and the diagnosis is not entertained. As two patients with possibly conflicting interests need to be managed, many ethical, psycho emotional and medical issues need to be simultaneously addressed. In this study, they analyzed management, complications, maternal and fetal outcomes in patients who were diagnosed with colorectal cancer during pregnancy or in the immediate postpartum period.
Around 0.1% of pregnant women develop a malignancy and there is limited experience on the management of colorectal cancer diagnosed during pregnancy or perinatal period. When colorectal cancer is detected in this period, treatment options may be limited.
In the authors’ experience with three patients who have undergone surgery during pregnancy, no adverse maternal and fetal outcomes were observed. There has been a significant delay in the diagnosis of these tumors which is probably due to overlap of symptoms and signs between colorectal malignancy and a normal pregnancy.
The treatment strategy for colorectal cancer should be no different for pregnant and non-pregnant patients in terms of the aim which is potential curative treatment of the disease. Considering the significant delay in the diagnosis of these tumors during pregnancy, new diagnostic modalities with reduced fetal side effects would facilitate diagnosis of colorectal cancer.
Patients who were diagnosed with colorectal cancer during pregnancy or in the postpartum period were analyzed in the study. The postpartum period is defined as first 6 mo after delivery.
In this retrospective study by Aytac et al the authors are presenting their experiences in the management of colorectal neoplasia during pregnancy and in the postpartum period. This is a well written paper with insightful, thoughtful and helpful observations which are a result of serious and hard work from an experienced team of experts in the field of colorectal surgery.
|1.||Tawadros PS, Paquette IM, Hanly AM, Mellgren AF, Rothenberger DA, Madoff RD. Adenocarcinoma of the rectum in patients under age 40 is increasing: impact of signet-ring cell histology. Dis Colon Rectum. 2015;58:474-478. [PubMed] [DOI]|
|2.||Salani R, Billingsley CC, Crafton SM. Cancer and pregnancy: an overview for obstetricians and gynecologists. Am J Obstet Gynecol. 2014;211:7-14. [PubMed] [DOI]|
|3.||Romano M, Cacciatore A, Giordano R, La Rosa B. Postpartum period: three distinct but continuous phases. J Prenat Med. 2010;4:22-25. [PubMed]|
|4.||Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007;56:1585-1589. [PubMed] [DOI]|
|5.||Bernstein MA, Madoff RD, Caushaj PF. Colon and rectal cancer in pregnancy. Dis Colon Rectum. 1993;36:172-178. [PubMed]|
|6.||Toosi M, Moaddabshoar L, Malek-Hosseini SA, Sasani MR, Mokhtari M, Mohammadianpanah M. Rectal cancer in pregnancy: a diagnostic and therapeutic challenge. J Egypt Natl Canc Inst. 2014;26:175-179. [PubMed] [DOI]|
|7.||Khodaverdi S, Kord Valeshabad A, Khodaverdi M. A Case of Colorectal Cancer during Pregnancy: A Brief Review of the Literature. Case Rep Obstet Gynecol. 2013;2013:626393. [PubMed] [DOI]|
|8.||Aytac E, Ozuner G, Isik O, Gorgun E, Remzi FH. Surgical management of patients with ulcerative colitis during pregnancy: maternal and fetal outcomes. J Crohns Colitis. 2015;9:82-85. [PubMed] [DOI]|
|9.||Brown JJ, Wilson C, Coleman S, Joypaul BV. Appendicitis in pregnancy: an ongoing diagnostic dilemma. Colorectal Dis. 2009;11:116-122. [PubMed] [DOI]|
|10.||Wang PI, Chong ST, Kielar AZ, Kelly AM, Knoepp UD, Mazza MB, Goodsitt MM. Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol. 2012;198:778-784. [PubMed] [DOI]|
|11.||Walker HG, Al Samaraee A, Mills SJ, Kalbassi MR. Laparoscopic appendicectomy in pregnancy: a systematic review of the published evidence. Int J Surg. 2014;12:1235-1241. [PubMed] [DOI]|
|12.||Yaghoobi M, Koren G, Nulman I. Challenges to diagnosing colorectal cancer during pregnancy. Can Fam Physician. 2009;55:881-885. [PubMed]|
|13.||Qureshi WA, Rajan E, Adler DG, Davila RE, Hirota WK, Jacobson BC, Leighton JA, Zuckerman MJ, Hambrick RD, Fanelli RD. ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc. 2005;61:357-362. [PubMed] [DOI]|
|14.||Lolis ED, Likoudis P, Voiniadis P, Hassiakos D, Samanides L. Synchronous rectal and colon cancer caused by familial polyposis coli during pregnancy. J Obstet Gynaecol Res. 2007;33:199-202. [PubMed] [DOI]|
|15.||Peccatori FA, Azim HA, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, Pentheroudakis G. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160-vi170. [PubMed] [DOI]|
|16.||Azim HA, Peccatori FA, Pavlidis N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev. 2010;36:101-109. [PubMed] [DOI]|
|17.||Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13:256-264. [PubMed] [DOI]|
|18.||Litton JK, Hodge S, Mattair D, Ramirez MM, Morrow PKH, Gonzalez-Angulo AM, Barnett CM, Hortobagyi GN, Theriault RL. Outcomes of children exposed to chemotherapy in utero for breast cancer. J Clin Oncol. 2011;29:Abstr 1099.|
|19.||Walsh C, Fazio VW. Cancer of the colon, rectum, and anus during pregnancy. The surgeon’s perspective. Gastroenterol Clin North Am. 1998;27:257-267. [PubMed]|